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Abstract
We report a case of a woman who underwent a curative resection of an upper jaw tumor histologically verified as eosinophilic 
granuloma. To exclude possible multiorgan involvement, PET/CT imaging was performed and revealed a metabolically active, 
partially calcified lesion located on the chest wall surface and clinically corresponding to a gradually developing, round, sub-
cutaneous infiltrate with erythematous overlying skin. After complete extirpation, the pathological finding was consistent with 
pilomatrixoma surprisingly, thus dismissing the suspected diagnosis of multi-system Langerhans cell histiocytosis.
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Introduction
Defined either as single-system or multi-system form, Langer-
hans cell histiocytosis encompasses diverse clinical manifesta-
tions with various treatment approaches and a wide prognostic 
spectrum; hence the name sometimes used to characterize the 
disease — chameleon-like. Virtually any part of the body may 
be affected, though most commonly involved are the skeletal 
system, skin and lungs [1]. We report a case of a woman with 
Langerhans cell histiocytosis demonstrating a diagnostic pitfall in 
fluorine-18-fluorodeoxyglucose (FDG) positron emission tomogra-
phy/computed tomography (PET/CT) scan imaging when searching 
for potential multicentric disease involvement.
Case report
A 67-year-old female, born in 1946, was referred to our de-
partment for further evaluation after resection of an upper jaw 
tumor at a dentistry clinic. Histopathological examination showed 
eosinophilic granuloma, a localized bone form of Langerhans cell 
histiocytosis. In order to exclude possible multifocal bone affection 
or involvement of other organs, the patient underwent PET/CT scan 
imaging revealing no residual hypermetabolism in the postresec-
tion area. However, a metabolically active (Maximum Standardized 
Uptake Value = 3.86, Figure 1 and 2, see red arrows), partially 
calcified lesion (14 mm in diameter, Figure 3, see blue arrow for 
the calcification) was identified located on the chest wall surface 
ventrolaterally at the level of the 7th rib-cartilage junction. Clinically, 
the infiltrate corresponded to a round subcutaneous lump with 
erythematous overlying skin, which had been slowly developing 
over a period of the past 3 years (Figure 4, see yellow arrow). After 
complete extirpation, the pathological finding was consistent with 
benign pilomatrixoma surprisingly, thus dismissing the suspected 
diagnosis of multi-system form of Langerhans cell histiocytosis. 
At 6 months after the surgical procedures, follow-up examina-
tions (clinical, dental panoramic radiograph) showed a sustained 
complete remission.
The PET/CT scanning was performed in euglycemia (blood glu-
cose level = 5.2 mmol/l) after fasting for 6 hours and an adequate 
oral pre-hydration with 500 mL of water. The scans were obtained 
after 60 min accumulation phase following intravenous application 
of FDG (UJV Rez, Czech Republic) in the dose of 314 MBq. Data 
acquisition on a hybrid PET/CT scanner (Biograph 64 True Point 
HR, Siemens, Erlangen, Germany) was carried out in two phases: 
(i) at the extent from the cranial base to the upper thighs with 
a high-dose contrast enhanced CT using 70 ml of intravenous iodine 
radiocontrast (Iomeron 400, Bracco, Milano, Italy), (ii) examination 
of the remaining lower extremities with a low dose non-contrast 
CT. Emission and transmission scans were reconstructed by us-
ing an iterative reconstruction algorithm. We evaluated PET scans, 
CT scans as well as fused PET/CT images. For semiquantitative 
analysis, SUVmax values were measured. The PET reconstruction 
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parameters were as follows: iterative reconstruction algorithm, 
OSEM, 4 iterations, 8 subsets, image size 168, zoom 1, Filter 
Gaussian, FWHM 6mm. The acquisition parameters for CT were 
as follows: slice 3 mm, Kernel B30f, Filter “PET medium smooth”, 
FoV 500 mm, reconstruction increment 3 mm.
Discussion
Being an uncommon idiopathic disorder, Langerhans cell histio-
cytosis is characterized by proliferation and accumulation of clonal 
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Figure 1. PET imaging, Maximum Intensity Projection. See red arrow 
for the metabolically active infiltration
Figure 2. PET/CT imaging, axial scans. See red arrow for the metabolically active infiltration
Figure 3. CT imaging, coronal scan. See blue arrow for the 
calcification
Figure 4. See yellow arrow for the clinical correlate
CT
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Langerhans cells in various tissues and organs resulting in abun-
dant clinical manifestations ranging from a single osteolytic lesion 
(eosinophilic granuloma) to widespread disease with multiorgan 
involvement. A recent observation of a high frequency of activat-
ing BRAFV600E mutations in lesional cells supports its classification 
as a neoplastic histiocytic condition [1]. Pilomatrixoma or calcifying 
epithelioma of Malherbe represents a rare benign skin appendageal 
tumor usually affecting the head and neck regions in children with 
a female predominance. Complete surgical excision as a potentially 
curative modality may fail in cases of a far less common malignant 
variant [2]. A differential diagnosis comprises varieties of benign 
(e.g. sebaceous cyst, giant cell tumor, foreign body reaction) as well 
as malignant (e.g. basal cell carcinoma) conditions. These are not 
always possible to be reliably distinguished by fine needle aspira-
tion biopsy or imaging methods [3]. Therefore, a histopathological 
evaluation is imperative. 
A June 2013 MEDLINE literature search using the keywords pi-
lomatrixoma and positron emission tomography retrieved two arti-
cles reporting on three adult patients with a solitary, metabolically 
active mass located in the head and neck area and initially mistaken 
for a carcinoma according to fine needle biopsy [4, 5]. The herein 
presented case of unicentric Langerhans cell histiocytosis coincid-
ing with FDG-PET positive pilomatrixoma demonstrates a possible 
oncologic pitfall for the clinicians underlined by the rarity of both 
these entities.
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